DK1345594T3 - Fast farmaceutisk sammensætning til kontrolleret frisætning af ivabradin - Google Patents
Fast farmaceutisk sammensætning til kontrolleret frisætning af ivabradinInfo
- Publication number
- DK1345594T3 DK1345594T3 DK01989654T DK01989654T DK1345594T3 DK 1345594 T3 DK1345594 T3 DK 1345594T3 DK 01989654 T DK01989654 T DK 01989654T DK 01989654 T DK01989654 T DK 01989654T DK 1345594 T3 DK1345594 T3 DK 1345594T3
- Authority
- DK
- Denmark
- Prior art keywords
- ivabradine
- pharmaceutical composition
- controlled release
- solid pharmaceutical
- thermoforming
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0017015A FR2818552B1 (fr) | 2000-12-26 | 2000-12-26 | Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine |
PCT/FR2001/004134 WO2002051387A1 (fr) | 2000-12-26 | 2001-12-21 | Composition pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1345594T3 true DK1345594T3 (da) | 2007-05-21 |
Family
ID=8858190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01989654T DK1345594T3 (da) | 2000-12-26 | 2001-12-21 | Fast farmaceutisk sammensætning til kontrolleret frisætning af ivabradin |
Country Status (27)
Country | Link |
---|---|
US (1) | US20040028743A1 (el) |
EP (1) | EP1345594B1 (el) |
JP (2) | JP2004518665A (el) |
KR (1) | KR100542472B1 (el) |
CN (1) | CN1203844C (el) |
AT (1) | ATE352290T1 (el) |
AU (1) | AU2002228119B2 (el) |
BR (1) | BR0116548A (el) |
CA (1) | CA2432645A1 (el) |
CY (1) | CY1106390T1 (el) |
CZ (1) | CZ304587B6 (el) |
DE (1) | DE60126332T2 (el) |
DK (1) | DK1345594T3 (el) |
EA (1) | EA005814B1 (el) |
ES (1) | ES2280420T3 (el) |
FR (1) | FR2818552B1 (el) |
HK (1) | HK1060514A1 (el) |
HU (1) | HU229410B1 (el) |
MX (1) | MXPA03005840A (el) |
NO (1) | NO333776B1 (el) |
NZ (1) | NZ526406A (el) |
PL (1) | PL203835B1 (el) |
PT (1) | PT1345594E (el) |
SI (1) | SI1345594T1 (el) |
SK (1) | SK286413B6 (el) |
WO (1) | WO2002051387A1 (el) |
ZA (1) | ZA200304441B (el) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2818552B1 (fr) * | 2000-12-26 | 2003-02-07 | Servier Lab | Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine |
FR2834896B1 (fr) * | 2002-01-23 | 2004-02-27 | Servier Lab | Composition pharmaceutique orodispersible d'ivabradine |
TWI357815B (en) * | 2003-06-27 | 2012-02-11 | Euro Celtique Sa | Multiparticulates |
US20060165790A1 (en) * | 2003-06-27 | 2006-07-27 | Malcolm Walden | Multiparticulates |
GB2418854B (en) | 2004-08-31 | 2009-12-23 | Euro Celtique Sa | Multiparticulates |
FR2882556B1 (fr) | 2005-02-28 | 2007-05-04 | Servier Lab | Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
FR2882553B1 (fr) | 2005-02-28 | 2007-05-04 | Servier Lab | Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
WO2010128525A2 (en) * | 2009-05-04 | 2010-11-11 | Dinesh Shantilal Patel | A formulation of ivabradine for treating the cardiovascular disease |
CA2800442C (en) | 2010-06-14 | 2018-05-22 | Ratiopharm Gmbh | Ivabradine-containing pharmaceutical composition with modified release |
CN101897682B (zh) * | 2010-07-13 | 2012-02-15 | 石药集团欧意药业有限公司 | 一种伊伐布雷定或其可药用盐固体制剂及其制备方法 |
CN102908327B (zh) * | 2011-08-05 | 2015-03-11 | 江苏恒瑞医药股份有限公司 | 伊伐布雷定或其可药用盐的缓释制剂 |
EP3082772A1 (en) * | 2013-12-20 | 2016-10-26 | Synhton B.V. | Pharmaceutical composition comprising amorphous ivabradine |
EP3025705B8 (en) | 2014-11-25 | 2018-11-28 | Sanofi Ilaç Sanayi ve Ticaret Anonim Sirketi | Stable ivabradine formulations |
CN104398486B (zh) * | 2014-12-08 | 2018-01-12 | 武汉武药科技有限公司 | 一种盐酸伊伐布雷定渗透泵控释片及其制备方法 |
EP3366282A1 (en) | 2017-02-28 | 2018-08-29 | Sanovel Ilac Sanayi ve Ticaret A.S. | Solid oral pharmaceutical compositions of ivabradine |
KR20190001340A (ko) * | 2017-06-27 | 2019-01-04 | 에리슨제약(주) | 이바브라딘을 포함하는 서방성 약제학적 조성물 및 이의 제조방법 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2681862B1 (fr) * | 1991-09-27 | 1993-11-12 | Adir Cie | Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent. |
DE4138513A1 (de) * | 1991-11-23 | 1993-05-27 | Basf Ag | Feste pharmazeutische retardform |
US5879705A (en) * | 1993-07-27 | 1999-03-09 | Euro-Celtique S.A. | Sustained release compositions of morphine and a method of preparing pharmaceutical compositions |
US5965161A (en) * | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
AU7106996A (en) * | 1995-09-07 | 1997-03-27 | Fuisz Technologies Ltd. | System for rendering substantially non-dissoluble bio-affecting agents bio-available |
KR100514264B1 (ko) * | 1997-08-26 | 2005-09-15 | 아벤티스 파마슈티칼스 인크. | 피페리디노알칸올-충혈완화제 조합용 제약 조성물 |
US6673367B1 (en) * | 1998-12-17 | 2004-01-06 | Euro-Celtique, S.A. | Controlled/modified release oral methylphenidate formulations |
DE19901040A1 (de) * | 1999-01-14 | 2000-07-20 | Knoll Ag | Arzneiformen mit gesteuerter Freisetzung, enthaltend gut wasserlösliche Wirkstoffe |
FR2795326B1 (fr) * | 1999-06-28 | 2001-08-31 | Adir | Composition pharmaceutique solide thermoformable a liberation controlee |
UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
FR2818552B1 (fr) * | 2000-12-26 | 2003-02-07 | Servier Lab | Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine |
-
2000
- 2000-12-26 FR FR0017015A patent/FR2818552B1/fr not_active Expired - Fee Related
-
2001
- 2001-12-21 KR KR1020037008654A patent/KR100542472B1/ko not_active IP Right Cessation
- 2001-12-21 US US10/451,903 patent/US20040028743A1/en not_active Abandoned
- 2001-12-21 BR BR0116548-8A patent/BR0116548A/pt not_active Application Discontinuation
- 2001-12-21 HU HU0302522A patent/HU229410B1/hu not_active IP Right Cessation
- 2001-12-21 AU AU2002228119A patent/AU2002228119B2/en not_active Ceased
- 2001-12-21 EP EP01989654A patent/EP1345594B1/fr not_active Expired - Lifetime
- 2001-12-21 DK DK01989654T patent/DK1345594T3/da active
- 2001-12-21 ES ES01989654T patent/ES2280420T3/es not_active Expired - Lifetime
- 2001-12-21 NZ NZ526406A patent/NZ526406A/en not_active IP Right Cessation
- 2001-12-21 MX MXPA03005840A patent/MXPA03005840A/es active IP Right Grant
- 2001-12-21 CZ CZ2003-2020A patent/CZ304587B6/cs not_active IP Right Cessation
- 2001-12-21 SI SI200130697T patent/SI1345594T1/sl unknown
- 2001-12-21 WO PCT/FR2001/004134 patent/WO2002051387A1/fr active IP Right Grant
- 2001-12-21 DE DE60126332T patent/DE60126332T2/de not_active Expired - Lifetime
- 2001-12-21 JP JP2002552533A patent/JP2004518665A/ja active Pending
- 2001-12-21 AT AT01989654T patent/ATE352290T1/de active
- 2001-12-21 PL PL361662A patent/PL203835B1/pl unknown
- 2001-12-21 CA CA002432645A patent/CA2432645A1/fr not_active Withdrawn
- 2001-12-21 EA EA200300667A patent/EA005814B1/ru not_active IP Right Cessation
- 2001-12-21 CN CNB018213677A patent/CN1203844C/zh not_active Expired - Fee Related
- 2001-12-21 SK SK942-2003A patent/SK286413B6/sk not_active IP Right Cessation
- 2001-12-21 PT PT01989654T patent/PT1345594E/pt unknown
-
2003
- 2003-06-06 ZA ZA200304441A patent/ZA200304441B/en unknown
- 2003-06-16 NO NO20032737A patent/NO333776B1/no not_active IP Right Cessation
-
2004
- 2004-05-17 HK HK04103476A patent/HK1060514A1/xx not_active IP Right Cessation
-
2007
- 2007-03-16 CY CY20071100370T patent/CY1106390T1/el unknown
-
2009
- 2009-12-25 JP JP2009295406A patent/JP2010100641A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200000584A2 (ru) | Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием | |
DK1345594T3 (da) | Fast farmaceutisk sammensætning til kontrolleret frisætning af ivabradin | |
TW200730200A (en) | Method for the preparation of a wet granulated drug product | |
DK1861073T3 (da) | Fremgangsmåde til fremstilling af calcium-kompositioner i en kontinuerlig fluid-bed | |
DE50012008D1 (de) | Zementzusammensetzungen, enthaltend redispergierbare Polymerisatpulver | |
HRP20090194T1 (en) | Dry granulated composition comprising emtricitabine and tenofovir df | |
MXPA03004832A (es) | Compuestos y sus usos. | |
EA200901393A1 (ru) | Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат | |
NO20013060D0 (no) | Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff | |
DK1210384T3 (da) | Uorganisk belægningssammensætning, en fremgangsmåde til fremstilling af denne samt anvendelse deraf | |
SE0004053D0 (sv) | N-type calcium channel antagonists for the treatment of pain | |
EA200201149A1 (ru) | Фармацевтические композиции и способы для предотвращения рецидива мигрени | |
EA200300664A1 (ru) | Твердая термоформируемая фармацевтическая композиция для контролируемого высвобождения периндоприла | |
WO2001022943A8 (en) | A slow release pharmaceutical composition comprising a magnesium oxychloride cement | |
AR032049A1 (es) | Una composicion farmaceutica solida termoformable para la liberacion controlada de trimetazidina | |
WO2004069228A3 (en) | Sustained release formulations of venlafaxine | |
PT1499278E (pt) | Forma de dosagem farmaceutica de libertacao imediata compreendendo tibolona polimorfa | |
BR0212254A (pt) | Composição farmaceutica | |
PL376537A1 (pl) | Kompozycje farmaceutyczne o przedłużonym, kontrolowanym uwalnianiu zawierające naładowane polimery | |
MXPA02012456A (es) | Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y materiales para su sintesis. | |
DE50211461D1 (de) | Pharmazeutische zusammensetzung enthaltend bulbophyllum | |
DK1144382T3 (da) | Fremgangsmåde til fremstilling af 3-substituerede 1,5-diarylpyrazoler | |
ECSP003358A (es) | Composiciones de betahistina de liberacion controlada |